Driscoll et al. reported no differences in serum sαKl between pre-symptomatic individuals who were positive vs. negative for Aβ or tau,23 suggesting no clear association between sαKl levels and early AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.